{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:54:42Z","timestamp":1791561282872,"version":"4.3.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T00:00:00Z","timestamp":1628812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T00:00:00Z","timestamp":1628812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s00277-021-04622-9","type":"journal-article","created":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T06:03:53Z","timestamp":1628834633000},"page":"2813-2824","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Poor outcome and high prevalence of invasive fungal infections in patients with adult T-cell leukemia\/lymphoma exposed to zidovudine and interferon alfa"],"prefix":"10.1007","volume":"100","author":[{"given":"Romain","family":"Guery","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe","family":"Suarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Lanternier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie Elisabeth","family":"Bougnoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9","family":"Lecuyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Avettand-Fenoel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Sibon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Frenzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Herl\u00e9","family":"Raphalen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Helias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Renaudier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florin","family":"Santa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Lecuit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Lortholary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Hermine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Aguilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6844-7920","authenticated-orcid":false,"given":"Ambroise","family":"Mar\u00e7ais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,13]]},"reference":[{"key":"4622_CR1","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3389\/fmicb.2012.00388","volume":"3","author":"A Gessain","year":"2012","unstructured":"Gessain A, Cassar O (2012) Epidemiological aspects and world distribution of HTLV-1 Infection. Front Microbiol 3:388. https:\/\/doi.org\/10.3389\/fmicb.2012.00388","journal-title":"Front Microbiol"},{"key":"4622_CR2","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/ijc.2910430214","volume":"43","author":"EL Murphy","year":"1989","unstructured":"Murphy EL, Hanchard B, Figueroa JP, Gibbs WN, Lofters WS, Campbell M et al (1989) Modelling the risk of adult T-cell leukemia\/lymphoma in persons infected with human T-lymphotropic virus type I. Int J Cancer 43:250\u2013253","journal-title":"Int J Cancer"},{"key":"4622_CR3","doi-asserted-by":"publisher","unstructured":"Shimoyama M, members of The Lymphoma Study Group (1984\u201387) (1991) Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. Br J Haematol 79:428\u201337. https:\/\/doi.org\/10.1111\/j.1365-2141.1991.tb08051.x.","DOI":"10.1111\/j.1365-2141.1991.tb08051.x"},{"key":"4622_CR4","doi-asserted-by":"publisher","unstructured":"Moriuchi Y, Yamada Y, Tomonaga M (1992) Infectious complications in patients with adult T-cell leukemia. J Jpn Assoc Infect Dis 66:1444\u20138. https:\/\/doi.org\/10.11150\/kansenshogakuzasshi1970.66.1444","DOI":"10.11150\/kansenshogakuzasshi1970.66.1444"},{"key":"4622_CR5","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1002\/1097-0142(19950401)75:7<1598::AID-CNCR2820750708>3.0.CO;2-7","volume":"75","author":"JD White","year":"1995","unstructured":"White JD, Zaknoen SL, Kasten-Sport\u00e8s C, Top LE, Navarro-Roman L, Nelson DL et al (1995) Infectious complications and immunodeficiency in patients with human T-cell lymphotropic virus I-associated adult T-cell leukemia\/lymphoma. Cancer 75:1598\u20131607","journal-title":"Cancer"},{"key":"4622_CR6","doi-asserted-by":"publisher","unstructured":"Bunn PAJr, Schechter GP, Jaffe E, Blayney D, Young RC, Matthews MJ et al (1983) Clinical course of retrovirus-associated adult T-cell lymphoma in the United States. N Engl J Med 309:257\u201364. https:\/\/doi.org\/10.1056\/NEJM198308043090501","DOI":"10.1056\/NEJM198308043090501"},{"key":"4622_CR7","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/932175","volume":"2012","author":"A Mar\u00e7ais","year":"2012","unstructured":"Mar\u00e7ais A, Suarez F, Sibon D, Bazarbachi A, Hermine O (2012) Clinical trials of adult T-cell leukaemia\/lymphoma treatment. Leuk Res Treat 2012:932175. https:\/\/doi.org\/10.1155\/2012\/932175","journal-title":"Leuk Res Treat"},{"key":"4622_CR8","doi-asserted-by":"publisher","first-page":"4177","DOI":"10.1200\/JCO.2010.28.0669","volume":"28","author":"A Bazarbachi","year":"2010","unstructured":"Bazarbachi A, Plumelle Y, Carlos Ramos J, Tortevoye P, Otrock Z, Taylor G et al (2010) Meta-analysis on the use of zidovudine and interferon-alfa in adult T-cell leukemia\/lymphoma showing improved survival in the leukemic subtypes. J Clin Oncol 28:4177\u20134183. https:\/\/doi.org\/10.1200\/JCO.2010.28.0669","journal-title":"J Clin Oncol"},{"key":"4622_CR9","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1200\/JCO.2009.25.3575","volume":"28","author":"K Yamamoto","year":"2010","unstructured":"Yamamoto K, Utsunomiya A, Tobinai K, Tsukasaki K, Uike N, Uozumi K et al (2010) Phase I study of KW-0761, a defucosylated humanized anti-CCR4 antibody, in relapsed patients with adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma. J Clin Oncol Off J Am Soc Clin Oncol 28:1591\u20131598. https:\/\/doi.org\/10.1200\/JCO.2009.25.3575","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"4622_CR10","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1111\/bjh.13338","volume":"169","author":"T Ishida","year":"2015","unstructured":"Ishida T, Jo T, Takemoto S, Suzushima H, Uozumi K, Yamamoto K et al (2015) Dose-intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma: a randomized phase II study. Br J Haematol 169:672\u2013682. https:\/\/doi.org\/10.1111\/bjh.13338","journal-title":"Br J Haematol"},{"key":"4622_CR11","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12977-020-0513-y","volume":"17","author":"A Mar\u00e7ais","year":"2020","unstructured":"Mar\u00e7ais A, Cook L, Witkover A, Asnafi V, Avettand-Fenoel V, Delarue R et al (2020) Arsenic trioxide (As2O3) as a maintenance therapy for adult T cell leukemia\/lymphoma. Retrovirology 17:5. https:\/\/doi.org\/10.1186\/s12977-020-0513-y","journal-title":"Retrovirology"},{"key":"4622_CR12","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1200\/JCO.2008.18.2428","volume":"27","author":"K Tsukasaki","year":"2008","unstructured":"Tsukasaki K, Hermine O, Bazarbachi A, Ratner L, Ramos JC, Harrington W et al (2008) Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting. J Clin Oncol 27:453\u2013459. https:\/\/doi.org\/10.1200\/JCO.2008.18.2428","journal-title":"J Clin Oncol"},{"key":"4622_CR13","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1182\/blood-2015-03-632489","volume":"126","author":"H Katsuya","year":"2015","unstructured":"Katsuya H, Ishitsuka K, Utsunomiya A, Hanada S, Eto T, Moriuchi Y et al (2015) Treatment and survival among 1594 patients with ATL. Blood 126:2570\u20132577. https:\/\/doi.org\/10.1182\/blood-2015-03-632489","journal-title":"Blood"},{"key":"4622_CR14","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.3201\/eid2007.140087","volume":"20","author":"D Bitar","year":"2014","unstructured":"Bitar D, Lortholary O, Le Strat Y, Nicolau J, Coignard B, Tattevin P et al (2014) Population-based analysis of invasive fungal infections, France, 2001\u20132010. Emerg Infect Dis 20:1149\u20131155. https:\/\/doi.org\/10.3201\/eid2007.140087","journal-title":"Emerg Infect Dis"},{"key":"4622_CR15","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1111\/j.1469-0691.2011.03548.x","volume":"17","author":"O Lortholary","year":"2011","unstructured":"Lortholary O, Gangneux J-P, Sitbon K, Lebeau B, de Monbrison F, Le Strat Y et al (2011) Epidemiological trends in invasive aspergillosis in France: the SAIF network (2005\u20132007). Clin Microbiol Infect 17:1882\u20131889. https:\/\/doi.org\/10.1111\/j.1469-0691.2011.03548.x","journal-title":"Clin Microbiol Infect"},{"key":"4622_CR16","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1007\/s00134-017-4743-y","volume":"43","author":"O Lortholary","year":"2017","unstructured":"Lortholary O, Renaudat C, Sitbon K, Desnos-Ollivier M, Bretagne S, Dromer F et al (2017) The risk and clinical outcome of candidemia depending on underlying malignancy. Intensive Care Med 43:652\u2013662. https:\/\/doi.org\/10.1007\/s00134-017-4743-y","journal-title":"Intensive Care Med"},{"key":"4622_CR17","unstructured":"Cordonnier C, Engelhard D, Ljungman P, Dekker A, Donnelly JP, Einsele H et al (2001) Definitions of infectious diseases and complications after stem cell transplant. Web Site EBMT"},{"key":"4622_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1086\/599376","volume":"49","author":"LA Mermel","year":"2009","unstructured":"Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O\u2019Grady NP et al (2009) Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 49:1\u201345. https:\/\/doi.org\/10.1086\/599376","journal-title":"Clin Infect Dis"},{"key":"4622_CR19","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"B De Pauw","year":"2008","unstructured":"De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T et al (2008) Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group. Clin Infect Dis Off Publ Infect Dis Soc Am 46:1813\u20131821. https:\/\/doi.org\/10.1086\/588660","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"4622_CR20","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1093\/jac\/dkw156","volume":"71","author":"A Alanio","year":"2016","unstructured":"Alanio A, Hauser PM, Lagrou K, Melchers WJG, Helweg-Larsen J, Matos O et al (2016) ECIL guidelines for the diagnosis of Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients. J Antimicrob Chemother 71:2386\u20132396. https:\/\/doi.org\/10.1093\/jac\/dkw156","journal-title":"J Antimicrob Chemother"},{"key":"4622_CR21","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/cid\/ciw668","volume":"64","author":"P Ljungman","year":"2017","unstructured":"Ljungman P, Boeckh M, Hirsch HH, Josephson F, Lundgren J, Nichols G et al (2017) Definitions of cytomegalovirus infection and disease in transplant patients for use in clinical trials. Clin Infect Dis Off Publ Infect Dis Soc Am 64:87\u201391. https:\/\/doi.org\/10.1093\/cid\/ciw668","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"4622_CR22","doi-asserted-by":"publisher","first-page":"5458","DOI":"10.1200\/JCO.2007.11.9958","volume":"25","author":"K Tsukasaki","year":"2007","unstructured":"Tsukasaki K, Utsunomiya A, Fukuda H, Shibata T, Fukushima T, Takatsuka Y et al (2007) VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801. J Clin Oncol Off J Am Soc Clin Oncol 25:5458\u20135464. https:\/\/doi.org\/10.1200\/JCO.2007.11.9958","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"4622_CR23","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1046\/j.1365-2141.2001.02737.x","volume":"113","author":"Y Yamada","year":"2001","unstructured":"Yamada Y, Tomonaga M, Fukuda H, Hanada S, Utsunomiya A, Tara M et al (2001) A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303. Br J Haematol 113:375\u2013382","journal-title":"Br J Haematol"},{"key":"4622_CR24","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1056\/NEJM199506293322603","volume":"332","author":"PS Gill","year":"1995","unstructured":"Gill PS, Harrington W, Kaplan MH, Ribeiro RC, Bennett JM, Liebman HA et al (1995) Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine. N Engl J Med 332:1744\u20131748. https:\/\/doi.org\/10.1056\/NEJM199506293322603","journal-title":"N Engl J Med"},{"key":"4622_CR25","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3109\/10428190109057927","volume":"40","author":"JD White","year":"2001","unstructured":"White JD, Wharfe G, Stewart DM, Maher VE, Eicher D, Herring B et al (2001) The combination of zidovudine and interferon alpha-2B in the treatment of adult T-cell leukemia\/lymphoma. Leuk Lymphoma 40:287\u2013294. https:\/\/doi.org\/10.3109\/10428190109057927","journal-title":"Leuk Lymphoma"},{"key":"4622_CR26","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1056\/NEJM199506293322604","volume":"332","author":"O Hermine","year":"1995","unstructured":"Hermine O, Bouscary D, Gessain A, Turlure P, Leblond V, Franck N et al (1995) Treatment of adult T-cell leukemia-lymphoma with zidovudine and interferon alfa. N Engl J Med 332:1749\u20131751","journal-title":"N Engl J Med"},{"key":"4622_CR27","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/sj.thj.6200195","volume":"3","author":"O Hermine","year":"2002","unstructured":"Hermine O, Allard I, L\u00e9vy V, Arnulf B, Gessain A, Bazarbachi A et al (2002) A prospective phase II clinical trial with the use of zidovudine and interferon-alpha in the acute and lymphoma forms of adult T-cell leukemia\/lymphoma. Hematol J Off J Eur Haematol Assoc EHA 3:276\u2013282. https:\/\/doi.org\/10.1038\/sj.thj.6200195","journal-title":"Hematol J Off J Eur Haematol Assoc EHA"},{"key":"4622_CR28","doi-asserted-by":"publisher","first-page":"e462","DOI":"10.3324\/haematol.2015.126698","volume":"100","author":"JC Teng","year":"2015","unstructured":"Teng JC, Slavin MA, Teh BW, Lingaratnam SM, Ananda-Rajah MR, Worth LJ et al (2015) Epidemiology of invasive fungal disease in lymphoproliferative disorders. Haematologica 100:e462-466. https:\/\/doi.org\/10.3324\/haematol.2015.126698","journal-title":"Haematologica"},{"key":"4622_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2343","author":"A Visentin","year":"2016","unstructured":"Visentin A, Gurrieri C, Imbergamo S, Lessi F, Di Maggio SA, Frezzato F et al (2016) Epidemiology and risk factors of invasive fungal infections in a large cohort of patients with chronic lymphocytic leukemia. Hematol Oncol. https:\/\/doi.org\/10.1002\/hon.2343","journal-title":"Hematol Oncol"},{"key":"4622_CR30","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1182\/bloodadvances.2017011106","volume":"2","author":"L Malpica","year":"2018","unstructured":"Malpica L, Pimentel A, Reis IM, Gotuzzo E, Lekakis L, Komanduri K et al (2018) Epidemiology, clinical features, and outcome of HTLV-1\u2013related ATLL in an area of prevalence in the United States. Blood Adv 2:607\u2013620. https:\/\/doi.org\/10.1182\/bloodadvances.2017011106","journal-title":"Blood Adv"},{"key":"4622_CR31","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3960\/jslrt.18032","volume":"59","author":"N Kawano","year":"2019","unstructured":"Kawano N, Nagahiro Y, Yoshida S, Tahara Y, Himeji D, Kuriyama T et al (2019) Clinical features and treatment outcomes of opportunistic infections among human T-lymphotrophic virus type 1 (HTLV-1) carriers and patients with adult T-cell leukemia-lymphoma (ATL) at a single institution from 2006 to 2016. J Clin Exp Hematop JCEH 59:156\u2013167. https:\/\/doi.org\/10.3960\/jslrt.18032","journal-title":"J Clin Exp Hematop JCEH"},{"key":"4622_CR32","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1200\/JCO.18.00501","volume":"37","author":"LB Cook","year":"2019","unstructured":"Cook LB, Fuji S, Hermine O, Bazarbachi A, Ramos JC, Ratner L et al (2019) Revised adult T-cell leukemia-lymphoma international consensus meeting report. J Clin Oncol Off J Am Soc Clin Oncol 37:677\u2013687. https:\/\/doi.org\/10.1200\/JCO.18.00501","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"4622_CR33","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/bmt.2015.265","volume":"51","author":"S Fuji","year":"2016","unstructured":"Fuji S, Fujiwara H, Nakano N, Wake A, Inoue Y, Fukuda T et al (2016) Early application of related SCT might improve clinical outcome in adult T-cell leukemia\/lymphoma. Bone Marrow Transplant 51:205. https:\/\/doi.org\/10.1038\/bmt.2015.265","journal-title":"Bone Marrow Transplant"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-021-04622-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-021-04622-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-021-04622-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T01:55:13Z","timestamp":1634090113000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-021-04622-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,13]]},"references-count":33,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["4622"],"URL":"https:\/\/doi.org\/10.1007\/s00277-021-04622-9","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,13]]},"assertion":[{"value":"19 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}